Sep 30

Scientific

SS 47 - Spine SBRT: Risk, Safety, and Outcomes

09:15am - 10:30am ET

Central Nervous System

MODERATOR(S)

Kristin Redmond, MD, MPH - Johns Hopkins University

Donna Edwards, MD, PhD - University of Michigan

Credits

AMA PRA Category 1 Credits:

1.25

Rate This Session

Presentations

09:15am - 09:25am ET

Prophylactic Cement Augmentation for Patients at High Risk for Developing Vertebral Body Compression Fracture Following Spine Stereotactic Radiosurgery: A Randomized Phase II Clinical Trial

Speaker: Amol Ghia, MD - MD Anderson Cancer Center, Houston
09:25am - 09:35am ET

Normal Tissue Complication Probability of Vertebral Compression Fracture for Stereotactic Body Radiotherapy for Spine Metastases: A Multi-Institutional Study

Speaker: Michael LeCompte, MD, MS - Southeast Radiation Oncology Group, Charlotte
09:35am - 09:45am ET

Validation of a Predictive Score for Vertebral Compression Fracture after Stereotactic Body Radiation Therapy for Spinal Metastases in an International Multi-Institutional Cohort

Speaker: Brianna Galvin, MD - Mayo Clinic Rochester, Rochester
09:45am - 09:55am ET

Is Reirradiation Spine SBRT with Spinal Cord Doses Exceeding HyTEC Constraints Safe and Effective?

Speaker: Terence Tang, MD, FRCPC - Sunnybrook Health Sciences Centre, Toronto
09:55am - 10:05am ET

Stereotactic Radiosurgery for Spinal Cord Arteriovenous Malformations: Dosimetric Correlates of Spinal Cord Toxicity

Speaker: Emily Smith, MD - Stanford Health Care, Stanford
10:05am - 10:15am ET

Impact of von-Hippel Lindau Mutations on Local Control after Spine Stereotactic Body Radiation Therapy for Renal Cell Carcinoma

Speaker: Elisa Liu, MD, BS - Memorial Sloan Kettering Cancer Center, New York
10:15am - 10:25am ET

Discussant

Speaker: Yoshiya Yamada, MD, FRCPC - Memorial Sloan Kettering Cancer Center, New York